Multimodality Imaging of Somatostatin Receptor–Positive Tumors with Nuclear and Bioluminescence Imaging
Multimodal bioluminescence (BLI) and single-photon emission computed tomography/computed tomography (SPECT/CT) imaging were investigated as means to monitor somatostatin receptor subtype 2 (SST 2 )-positive neuroendocrine tumors as both a subcutaneously implanted and a liver metastasis animal model...
Saved in:
Main Authors: | Stefan E. Pool, Timo L.M. ten Hagen, Stuart Koelewijn, Marion de Jong, Gerben A. Koning |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-01-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2011.00024 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Histopathological Evaluation of Somatostatin Receptor 2 Expression in Myocarditis—Rationale for the Diagnostic Use of Somatostatin Receptor Imaging
by: Christian L. Polte, et al.
Published: (2024-10-01) -
Somatostatin Receptor Imaging in the Diagnosis and Management of Parathyroid Neuroendocrine Neoplasia
by: Uliana Tsoy, et al.
Published: (2024-12-01) -
Signaling Can Be Uncoupled from Imaging of the Somatostatin Receptor Type 2
by: Lin Han, et al.
Published: (2007-11-01) -
[89Zr]Zr-DFO-TOC: a novel radiopharmaceutical for PET imaging of somatostatin receptor positive neuroendocrine tumors
by: Alexis M. Sanwick, et al.
Published: (2024-12-01) -
Bioluminescence Imaging of Gene Expression in Utero
by: Meera T. Saxena, et al.
Published: (2007-01-01)